Zerbini LF

Zerbini LF

Zerbini LF is  Group Leader of Cancer Genomics Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), South Africa

Biography
Education University of Sao Paulo (USP),Molecular Virology, São Paulo, Brazil, PhD, 1999 Federal University of Sao Paulo, Paulista Medicine School, São Paulo, Brazil, Master in Science, 1993 Campinas State University (UNICAMP), Campinas, Brazil, BSc in Biomedical Sciences, 1989 Career History Since 2009, Group Leader Cancer Genomics Group, International Centre for Genetic engineer and Biotechnology, Cape Town, South Africa 2004-2009, Faculty Instructor in Medicine, Harvard Medical School, Boston, USA 2004-2009, Associate Director, Research Proteomics, BIDMC Genomics Center and DFHC Proteomics Core, Boston, USA 2003-2004, Senior Research Scientist, BIDMC Genomics Center, Harvard Medical School, Boston, USA 1999-2003, Postdoctoral Fellow, BIDMC Genomics Center, Harvard Medical School, Boston, USA 1994-1995, Assistant Professor, Department of Microbiology, Paulista Medicine School, São Paulo, Brazil
Research Interest
The overall goals of the laboratory are to utilize genomics and proteomics tools and signal transduction resources to accelerate comparative analysis of aberrant gene expression in carcinogenesis and to study alterations in signal transduction pathways during development of cancers. Areas of research include: regulation of gene expression by transcription factors, the role of receptor tyrosine kinases in cancer malignancies, aberrant gene expression in carcinogenesis and alterations in signal transduction pathways and gene translocations.